Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Study description
Evidenza dal mondo reale dell'efficacia e dell'utilizzo nella pratica clinica di Glecaprevir più Pibrentasvir in pazienti affetti da Epatite C cronica genotipi da 1 a 6
Pathology
Hepatitis C Virus HCV
Study type
Post-marketing observation study
Status
Active
Study start date
2017
Funder Type
Industry funded study
Investigator
Dr. med. Lorenzo MAGENTA
Recruitment
Recruiting
For information, please contact the Foundation